← Back to search
AVAILS MEDICAL, INC
MENLO PARK, CA, 94025
UnclaimedClaim this profile (free)
Subcontracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | AVAILS MEDICAL, INC. IS AN IN VITRO DIAGNOSTICS COMPANY DEDICATED TO PROVIDING SOLUTIONS FOR THE GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE AND HEALTHCARE ASSOCIATED INFECTIONS, BEGINNING WITH THE BACTEREMIA DIAGNOSTICS MARKET. WITH THE CURRENT STANDARD OF CARE AND WIDESPREAD USE OF LEGACY ANTIBIOTIC SUSCEPTIBILITY TESTING (AST) SYSTEMS, DETERMINING THE ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AN ORGANISM CAUSING A BLOOD STREAM INFECTION CAN TAKE SEVERAL DAYS WHICH DELAYS APPROPRIATE TREATMENT AND ULTIMATELY INCREASES MORTALITY RATES. ADDRESSING THIS NEED FOR FASTER AST RESULTS, AVAILS HAS USED ITS ELECTRICAL BIOSENSOR TECHNOLOGY TO DEVELOP AN €ˌEAST€„¢ SYSTEM WHICH CONSISTS OF AN ELID CONSUMABLE AND AN EAST READER WHICH ARE USED IN CONJUNCTION WITH CUSTOMIZED 96 WELL AST PLATES. THE ELID CONSUMABLE IS COMPOSED OF 96 ELECTRICAL SENSORS INTEGRATED INTO A LID THAT FITS THE 96 WELL AST PLATE WHICH HAS BEEN INOCULATED WITH THE POSITIVE BLOOD CULTURE SAMPLE (OR BACTERIAL COLONIES IN SUSPENSION). EAST PROVIDES A RAPID PLATFORM ABLE TO MONITOR BACTERIAL METABOLITE PRODUCTION IN REAL-TIME TO ACCURATELY IDENTIFY THE MINIMAL INHIBITORY CONCENTRATIONS (MIC) AND THE MOST EFFECTIVE ANTIBIOTICS. THIS AWARD WILL BE USED TO FUND THE RESEARCH AND FEASIBILITY TESTING REQUIRED TO EXPAND THE NUMBER OF ORGANISMS AND ANTIBIOTICS SUPPORTED BY EAST, ALONG WITH STUDIES DESIGNED TO TEST THE REPRODUCIBILITY OF RESULTS AND TO CHALLENGE THE SYSTEM. THE AWARD WILL ALSO SUPPORT THE CONTINUING DESIGN AND IMPROVEMENT OF THE ELID CONSUMABLE AND THE SINGLE SLOT READER, FOCUSSING ON ALGORITHM IMPLEMENTATION AND SOFTWARE INTEGRATION. FOLLOWING THIS STAGE, THE FUNDS WILL BE USED IN THE DESIGN AND BUILD OF A PROTOTYPE 10 SLOT READER EQUIPPED WITH LIS CONNECTIVITY. THE PROJECT WILL CULMINATE IN AN EXTERNAL PERFORMANCE EVALUATION STUDY, WHERE CLINICAL SAMPLES WILL BE TESTED IN A CLINICAL LABORATORY USING THE AVAILS EAST SYSTEM. 4500004337 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | -$120,000 | Dec 14, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | AVAILS MEDICAL, INC. IS AN IN VITRO DIAGNOSTICS COMPANY DEDICATED TO PROVIDING SOLUTIONS FOR THE GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE AND HEALTHCARE ASSOCIATED INFECTIONS, BEGINNING WITH THE BACTEREMIA DIAGNOSTICS MARKET. WITH THE CURRENT STANDARD OF CARE AND WIDESPREAD USE OF LEGACY ANTIBIOTIC SUSCEPTIBILITY TESTING (AST) SYSTEMS, DETERMINING THE ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AN ORGANISM CAUSING A BLOOD STREAM INFECTION CAN TAKE SEVERAL DAYS WHICH DELAYS APPROPRIATE TREATMENT AND ULTIMATELY INCREASES MORTALITY RATES. ADDRESSING THIS NEED FOR FASTER AST RESULTS, AVAILS HAS USED ITS ELECTRICAL BIOSENSOR TECHNOLOGY TO DEVELOP AN €ˌEAST€„¢ SYSTEM WHICH CONSISTS OF AN ELID CONSUMABLE AND AN EAST READER WHICH ARE USED IN CONJUNCTION WITH CUSTOMIZED 96 WELL AST PLATES. THE ELID CONSUMABLE IS COMPOSED OF 96 ELECTRICAL SENSORS INTEGRATED INTO A LID THAT FITS THE 96 WELL AST PLATE WHICH HAS BEEN INOCULATED WITH THE POSITIVE BLOOD CULTURE SAMPLE (OR BACTERIAL COLONIES IN SUSPENSION). EAST PROVIDES A RAPID PLATFORM ABLE TO MONITOR BACTERIAL METABOLITE PRODUCTION IN REAL-TIME TO ACCURATELY IDENTIFY THE MINIMAL INHIBITORY CONCENTRATIONS (MIC) AND THE MOST EFFECTIVE ANTIBIOTICS. THIS AWARD WILL BE USED TO FUND THE RESEARCH AND FEASIBILITY TESTING REQUIRED TO EXPAND THE NUMBER OF ORGANISMS AND ANTIBIOTICS SUPPORTED BY EAST, ALONG WITH STUDIES DESIGNED TO TEST THE REPRODUCIBILITY OF RESULTS AND TO CHALLENGE THE SYSTEM. THE AWARD WILL ALSO SUPPORT THE CONTINUING DESIGN AND IMPROVEMENT OF THE ELID CONSUMABLE AND THE SINGLE SLOT READER, FOCUSSING ON ALGORITHM IMPLEMENTATION AND SOFTWARE INTEGRATION. FOLLOWING THIS STAGE, THE FUNDS WILL BE USED IN THE DESIGN AND BUILD OF A PROTOTYPE 10 SLOT READER EQUIPPED WITH LIS CONNECTIVITY. THE PROJECT WILL CULMINATE IN AN EXTERNAL PERFORMANCE EVALUATION STUDY, WHERE CLINICAL SAMPLES WILL BE TESTED IN A CLINICAL LABORATORY USING THE AVAILS EAST SYSTEM. 4500004337 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | -$650,000 | Nov 3, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | AVAILS MEDICAL, INC. IS AN IN VITRO DIAGNOSTICS COMPANY DEDICATED TO PROVIDING SOLUTIONS FOR THE GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE AND HEALTHCARE ASSOCIATED INFECTIONS, BEGINNING WITH THE BACTEREMIA DIAGNOSTICS MARKET. WITH THE CURRENT STANDARD OF CARE AND WIDESPREAD USE OF LEGACY ANTIBIOTIC SUSCEPTIBILITY TESTING (AST) SYSTEMS, DETERMINING THE ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AN ORGANISM CAUSING A BLOOD STREAM INFECTION CAN TAKE SEVERAL DAYS WHICH DELAYS APPROPRIATE TREATMENT AND ULTIMATELY INCREASES MORTALITY RATES. ADDRESSING THIS NEED FOR FASTER AST RESULTS, AVAILS HAS USED ITS ELECTRICAL BIOSENSOR TECHNOLOGY TO DEVELOP AN €ˌEAST€„¢ SYSTEM WHICH CONSISTS OF AN ELID CONSUMABLE AND AN EAST READER WHICH ARE USED IN CONJUNCTION WITH CUSTOMIZED 96 WELL AST PLATES. THE ELID CONSUMABLE IS COMPOSED OF 96 ELECTRICAL SENSORS INTEGRATED INTO A LID THAT FITS THE 96 WELL AST PLATE WHICH HAS BEEN INOCULATED WITH THE POSITIVE BLOOD CULTURE SAMPLE (OR BACTERIAL COLONIES IN SUSPENSION). EAST PROVIDES A RAPID PLATFORM ABLE TO MONITOR BACTERIAL METABOLITE PRODUCTION IN REAL-TIME TO ACCURATELY IDENTIFY THE MINIMAL INHIBITORY CONCENTRATIONS (MIC) AND THE MOST EFFECTIVE ANTIBIOTICS. THIS AWARD WILL BE USED TO FUND THE RESEARCH AND FEASIBILITY TESTING REQUIRED TO EXPAND THE NUMBER OF ORGANISMS AND ANTIBIOTICS SUPPORTED BY EAST, ALONG WITH STUDIES DESIGNED TO TEST THE REPRODUCIBILITY OF RESULTS AND TO CHALLENGE THE SYSTEM. THE AWARD WILL ALSO SUPPORT THE CONTINUING DESIGN AND IMPROVEMENT OF THE ELID CONSUMABLE AND THE SINGLE SLOT READER, FOCUSSING ON ALGORITHM IMPLEMENTATION AND SOFTWARE INTEGRATION. FOLLOWING THIS STAGE, THE FUNDS WILL BE USED IN THE DESIGN AND BUILD OF A PROTOTYPE 10 SLOT READER EQUIPPED WITH LIS CONNECTIVITY. THE PROJECT WILL CULMINATE IN AN EXTERNAL PERFORMANCE EVALUATION STUDY, WHERE CLINICAL SAMPLES WILL BE TESTED IN A CLINICAL LABORATORY USING THE AVAILS EAST SYSTEM. 4500004337 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | $1,810,534 | Apr 26, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | AVAILS MEDICAL, INC. IS AN IN VITRO DIAGNOSTICS COMPANY DEDICATED TO PROVIDING SOLUTIONS FOR THE GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE AND HEALTHCARE ASSOCIATED INFECTIONS, BEGINNING WITH THE BACTEREMIA DIAGNOSTICS MARKET. WITH THE CURRENT STANDARD OF CARE AND WIDESPREAD USE OF LEGACY ANTIBIOTIC SUSCEPTIBILITY TESTING (AST) SYSTEMS, DETERMINING THE ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AN ORGANISM CAUSING A BLOOD STREAM INFECTION CAN TAKE SEVERAL DAYS WHICH DELAYS APPROPRIATE TREATMENT AND ULTIMATELY INCREASES MORTALITY RATES. ADDRESSING THIS NEED FOR FASTER AST RESULTS, AVAILS HAS USED ITS ELECTRICAL BIOSENSOR TECHNOLOGY TO DEVELOP AN €ˌEAST€„¢ SYSTEM WHICH CONSISTS OF AN ELID CONSUMABLE AND AN EAST READER WHICH ARE USED IN CONJUNCTION WITH CUSTOMIZED 96 WELL AST PLATES. THE ELID CONSUMABLE IS COMPOSED OF 96 ELECTRICAL SENSORS INTEGRATED INTO A LID THAT FITS THE 96 WELL AST PLATE WHICH HAS BEEN INOCULATED WITH THE POSITIVE BLOOD CULTURE SAMPLE (OR BACTERIAL COLONIES IN SUSPENSION). EAST PROVIDES A RAPID PLATFORM ABLE TO MONITOR BACTERIAL METABOLITE PRODUCTION IN REAL-TIME TO ACCURATELY IDENTIFY THE MINIMAL INHIBITORY CONCENTRATIONS (MIC) AND THE MOST EFFECTIVE ANTIBIOTICS. THIS AWARD WILL BE USED TO FUND THE RESEARCH AND FEASIBILITY TESTING REQUIRED TO EXPAND THE NUMBER OF ORGANISMS AND ANTIBIOTICS SUPPORTED BY EAST, ALONG WITH STUDIES DESIGNED TO TEST THE REPRODUCIBILITY OF RESULTS AND TO CHALLENGE THE SYSTEM. THE AWARD WILL ALSO SUPPORT THE CONTINUING DESIGN AND IMPROVEMENT OF THE ELID CONSUMABLE AND THE SINGLE SLOT READER, FOCUSSING ON ALGORITHM IMPLEMENTATION AND SOFTWARE INTEGRATION. FOLLOWING THIS STAGE, THE FUNDS WILL BE USED IN THE DESIGN AND BUILD OF A PROTOTYPE 10 SLOT READER EQUIPPED WITH LIS CONNECTIVITY. THE PROJECT WILL CULMINATE IN AN EXTERNAL PERFORMANCE EVALUATION STUDY, WHERE CLINICAL SAMPLES WILL BE TESTED IN A CLINICAL LABORATORY USING THE AVAILS EAST SYSTEM. 4500004337 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | $1,318,490 | Aug 29, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.